Kang Soosung, Kang Byoung Heon
College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea.
J Med Chem. 2022 Dec 22;65(24):16155-16172. doi: 10.1021/acs.jmedchem.2c01633. Epub 2022 Dec 12.
Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial molecular chaperone modulating cellular metabolism and signaling pathways by altering the conformation, activity, and stability of numerous substrate proteins called clients. It exerts its chaperone function as an adaptive response to counter cellular stresses instead of maintaining housekeeping protein homeostasis. However, the stress-adaptive machinery becomes dysregulated to support the progression and maintenance of human diseases, such as cancers; therefore, TRAP1 has been proposed as a promising target protein for anticancer drug development. In this review, by collating recent reports on high-resolution TRAP1 structures and structure-activity relationships of inhibitors, we aimed to provide better insights into the chaperoning mechanism of the emerging drug target and to suggest an efficient strategy for the development of potent TRAP1 inhibitors.
肿瘤坏死因子受体相关蛋白1(TRAP1)是一种线粒体分子伴侣,通过改变众多被称为底物蛋白(客户蛋白)的构象、活性和稳定性来调节细胞代谢和信号通路。它发挥伴侣功能是作为一种适应性反应来应对细胞应激,而非维持管家蛋白的稳态。然而,这种应激适应机制会失调,以支持人类疾病(如癌症)的进展和维持;因此,TRAP1已被提议作为抗癌药物开发的一个有前景的靶蛋白。在本综述中,通过整理有关TRAP1高分辨率结构和抑制剂构效关系的最新报告,我们旨在更好地洞察这个新兴药物靶点的伴侣机制,并提出开发强效TRAP1抑制剂的有效策略。